Basic Information
Basic information for LINC01010-214-11aa
Peptide Name LINC01010-214-11aa
Genome Position chr6:134503257-134503289[+]
Species Human
Peptide Sequence MELRVGGQGSI
Peptide Length 11
Unique No (LINC01010-201-11aa,LINC01010-202-11aa,LINC01010-203-11aa,LINC01010-204-11aa,LINC01010-205-11aa,LINC01010-206-11aa,LINC01010-207-11aa,LINC01010-208-11aa,LINC01010-209-11aa-2,LINC01010-210-11aa,LINC01010-211-11aa,LINC01010-212-11aa,LINC01010-213-11aa,LINC01010-215-11aa,LINC01010-216-11aa)
Grand Average of Hydropathicity 0.0818
Relative Molecular Mass 1326.48
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000236700;LINC01010
Transcript ID/Name ENST00000667755;LINC01010-214
Transcript Length 1263
Coding Ability 0.4949
DNA Sequence Corresponding to Peptide ATGGAGCTCAGAGTGGGAGGTCAGGGCAGTATT
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :